1-11 of 11
Marion Heinzelmann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prospective Multicenter Phase 3 Study Comparing 5-Azacytidine (5-Aza) Induction Followed By Allogeneic Stem Cell Transplantation Versus Continuous 5-Aza According to Donor Availability in Elderly MDS Patients (55-70 years) (VidazaAllo Study)

Nicolaus Kroeger, Katja Sockel, MD, Christine Wolschke, MD, Wolfgang Bethge, MD, Richard F. Schlenk, MD, Dominik Wolf‎, MD, Michael Stadler, MD PhD, Guido Kobbe, Gerald Wulf, MD, Gesine Bug, Kerstin Schäfer-Eckart, MD, Christoph Scheid, MD, Florian Nolte, MD, Jan Krönke, MD, Matthias Stelljes, MD, Dietrich W. Beelen, Marion Heinzelmann, Detlef Haase, MD PhD, Hannes Buchner, Dr., Gabriele Bleckert, Dr., Uwe Platzbecker
Journal: Blood
Blood (2018) 132 (Supplement 1): 208.
https://doi.org/10.1182/blood-2018-99-115932
Published: 2018
Journal Articles

Prevention of Chronic GvHD after HLA-Identical Sibling Peripheral Hematopietic Stem Cell Transplantation with or without Anti-Lymphocyte Globulin (ATG). Results from a Prospective, Multicenter Randomized Phase III Trial (ATGfamilystudy)

Francesca Bonifazi, MD, Carlos Solano, MD, Christine Wolschke, MD, Francesca Patriarca, MD, Massimo Pini, MD, Arnon Nagler, MD, Mino Selleri, MD, Giuseppe Messina, MD, Wolfgang A. Bethge, MD, Pilar Herrera Fuente, MD, Rafael F Duarte, MD, Nicola Cascavilla, MD, Michele Cimminiello, Stefano Guidi, MD, Jürgen Finke, MD, Andrea Gallamini, MD, Christelle Ferrà, MD, Jorge Sierra, MD, Domenico Russo, MD, Mario Petrini, MD, Giuseppe Milone, MD, Fabio Benedetti, MD, Marion Heinzelmann, Vincenzo Liso, MD, Manuel Jurado, MD, Enrico Maria Pogliani, MD, Franco Narni, Andreas Völp, Giuseppe Bandini, MD, Francis Ayuk, MD, Nicolaus Kröger, MD
Journal: Blood
Blood (2014) 124 (21): 37.
https://doi.org/10.1182/blood.V124.21.37.37
Published: 2014
Journal Articles

The Pan- JAK Inhibitor Ruxolitinib Impairs T-Cell Activation, Cytokine Production and Proliferation In Vivo and In Vitro

Thomas Stuebig, MD, Christine Wolschke, MD, Haefaa Alchalby, MD, Francis Ayuk, MD, Marion Heinzelmann, Ioanna Triviai, PhD, Anita Badbaran, York Hildebrandt, Nicolaus Kroeger, MD
Journal: Blood
Blood (2013) 122 (21): 2001.
https://doi.org/10.1182/blood.V122.21.2001.2001
Published: 2013
Journal Articles

Dose Finding Study of Lenalidomide as Maintenance Therapy In Multiple Myeloma After Allogeneic Stem Cell Transplantation

Christine Wolschke, Stefan O Schonland, Ute Hegenbart, Thomas Stübig, Marion Heinzelmann, York Hildebrandt, Michael Lioznov, Axel R. Zander, MD, Nicolaus Kröger, MD
Journal: Blood
Blood (2010) 116 (21): 2376.
https://doi.org/10.1182/blood.V116.21.2376.2376
Published: 2010
Journal Articles

Related Vs Unrelated Donors After Auto-Allo Tandem Stem Cell Transplantation for Newly Diagnosed Patients with Multiple Myeloma.

Nicolaus Kröger, MD, Tatjana Zabelina, Marion Heinzelmann, Georgia Schilling, Christine Wolschke, Heinrich Lellek, Thomas Stübig, Maite Lestin, Haefaa Alchalby, Francis Ayuk, Djordje Atanackovic, M.D., Ulrike Bacher, Boris Fehse, Axel R. Zander
Journal: Blood
Blood (2009) 114 (22): 1201.
https://doi.org/10.1182/blood.V114.22.1201.1201
Published: 2009
Journal Articles

Unrelated Stem Cell Transplantation After Reduced Intensity Conditioning for Patients with Multiple Myeloma Relapsing After Autologous Transplantation A Prospective Multicenter Phase II Study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Nicolaus Kröger, MD, Avichai Shimoni, Georgia Schilling, Rainer Schwerdtfeger, MD, Martin Bornhäuser, Arnon Nagler, Axel R. Zander, Marion Heinzelmann, Ronald Brand, Goesta Gahrton, MD, PhD, Currly Morris, Dietger Niederwieser, T. M. de Witte
Journal: Blood
Blood (2009) 114 (22): 2308.
https://doi.org/10.1182/blood.V114.22.2308.2308
Published: 2009
Journal Articles

Dose-Reduced Conditioning Followed by Allogeneic Stem Cell Transplantation in Patients with Myelofibrosis. Results from a Multicenter Prospective Trial of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Nicolaus Kroeger, MD, Ernst Holler, MD, Guido Kobbe, MD, Martin Bornhaeuser, MD, Rainer Schwerdtfeger, MD, Arnon Nagler, MD, Wolfgang Bethge, MD, Matthias Stelljes, MD, Lutz Uharek, MD, Hannes Wandt, MD, Marleen van Os, Andreas Burchert, MD, Paolo Corradini, MD, Joerg Schubert, MD, Martin Kaufmann, MD, Peter Dreger, MD, Gerald Wulf, MD, Hermann Einsele, MD, Martin Gramatzki, MD, Tatjana Zabelina, MD, Ulrike Bacher, MD, Axel Zander, MD, Marion Heinzelmann, Michael Kvasnicka, MD, Juergen Thiele, MD, Dietger Niederwieser, MD, Theo de Witte, MD
Journal: Blood
Blood (2007) 110 (11): 683.
https://doi.org/10.1182/blood.V110.11.683.683
Published: 2007
Journal Articles

Antifungal Prophylaxis in Allogeneic Stem Cell Transplantation: Results of a Retrospective Cohort Study.

Christine Wolschke, MD, Heinrich Lellek, MD, Marion Heinzelmann, RN, Nicolaus Kroeger, MD, Axel Zander, MD
Journal: Blood
Blood (2007) 110 (11): 5004.
https://doi.org/10.1182/blood.V110.11.5004.5004
Published: 2007
Journal Articles

Pegfilgastrim after Allogeneic Transplantation - A Alternative to Daily Filgastrim?.

Christine Wolschke, MD, Tatjana Zabelina, MD, Marion Heinzelmann, RN, Joachim Dahlke, MD, Nicolaus M. Kroeger, MD, Axel R. Zander, MD
Journal: Blood
Blood (2005) 106 (11): 5306.
https://doi.org/10.1182/blood.V106.11.5306.5306
Published: 2005
Journal Articles

Early In Vivo Depletion of Suicide Gene-Modified T-Lymphocytes Transplanted in Conjunction with CD34 + Enriched Blood Stem Cells May Be Associated with an Increased Risk of Secondary Graft Failure.

Boris Fehse, PhD, Francis A. Ayuk, MD, Nicolaus Kröger, MD, Lubin Fang, MD, Klaus Kühlcke, PhD, Marion Heinzelmann, Tatjana Zabelina, MD, Axel A. Fauser, MD, PhD, Axel R. Zander, MD
Journal: Blood
Blood (2004) 104 (11): 1742.
https://doi.org/10.1182/blood.V104.11.1742.1742
Published: 2004
Journal Articles

Evidence for increased risk of secondary graft failure after in vivo depletion of suicide gene-modified T lymphocytes transplanted in conjunction with CD34 + -enriched blood stem cells

Boris Fehse, Francis A. Ayuk, Nicolaus Kröger, Lubin Fang, Klaus Kühlcke, Marion Heinzelmann, Tatjana Zabelina, Axel A. Fauser, Axel R. Zander
Journal: Blood
Blood (2004) 104 (10): 3408–3409.
https://doi.org/10.1182/blood-2004-07-2813
Published: 2004